Interactions of alkali cations with glutamate transporters

por Holley, David C., Kavanaugh, Michael P.
Publicado 2008

Specificity and Actions of an Arylaspartate Inhibitor of Glutamate Transport at the Schaffer Collateral-CA1 Pyramidal Cell Synapse

por Sun, Weinan, Hoffman, Katie M., Holley, David C., Kavanaugh, Michael P.
Publicado 2011

Novel Dicarboxylate Selectivity in an Insect Glutamate Transporter Homolog

por Wang, Hui, Rascoe, Avi M., Holley, David C., Gouaux, Eric, Kavanaugh, Michael P.
Publicado 2013

Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice

por Gnanaprakash, Madhumathi, Staniszewski, Agnieszka, Zhang, Hong, Pitstick, Rose, Kavanaugh, Michael P., Arancio, Ottavio, Nicholls, Russell E.
Publicado 2021

Generation and characterization of a knock-in mouse model for Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM)

por Ratz, Megan L., Leary, Greg, Grindeland, Andrea, Silvius, Derek, Guter, Joseph, Kavanaugh, Michael P., Gunn, Teresa M.
Publicado 2023

Octopamine Neuromodulation Regulates Gr32a-Linked Aggression and Courtship Pathways in Drosophila Males

por Andrews, Jonathan C., Fernández, María Paz, Yu, Qin, Leary, Greg P., Leung, Adelaine K. W., Kavanaugh, Michael P., Kravitz, Edward A., Certel, Sarah J.
Publicado 2014

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures

por Foster, Alan C., Farnsworth, Jill, Lind, Genevieve E., Li, Yong-Xin, Yang, Jia-Ying, Dang, Van, Penjwini, Mahmud, Viswanath, Veena, Staubli, Ursula, Kavanaugh, Michael P.
Publicado 2016

Supplemental Ascorbate Diminishes DNA Damage Yet Depletes Glutathione and Increases Acute Liver Failure in a Mouse Model of Hepatic Antioxidant System Disruption

por Miller, Colin G., Kundert, Jean A., Prigge, Justin R., Amato, Julie A., Perez, Allison E., Coppo, Lucia, Rizzo, Gabrielle N., Kavanaugh, Michael P., Orlicky, David J., Shearn, Colin T., Schmidt, Edward E.
Publicado 2021

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

por Minikel, Eric Vallabh, Zhao, Hien T, Le, Jason, O’Moore, Jill, Pitstick, Rose, Graffam, Samantha, Carlson, George A, Kavanaugh, Michael P, Kriz, Jasna, Kim, Jae Beom, Ma, Jiyan, Wille, Holger, Aiken, Judd, McKenzie, Deborah, Doh-ura, Katsumi, Beck, Matthew, O’Keefe, Rhonda, Stathopoulos, Jacquelyn, Caron, Tyler, Schreiber, Stuart L, Carroll, Jeffrey B, Kordasiewicz, Holly B, Cabin, Deborah E, Vallabh, Sonia M
Publicado 2020